avi-7100
Nucleic acidexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2011 (NCT01375985)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza virusANTISENSE INHIBITOR
Influenza virus antisense inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- avi-7100
- avi-7100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01747148 | Phase 1 | Nov 14, 2012 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01375985 | Phase 1 | Jun 1, 2011 | Covance, Sarepta Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Covance | For profit | 1 | 0 | 1 | 2011 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2012 |
| Sarepta Therapeutics | For profit | 1 | 1 | 1 | 2011 |
3 organizations
Page 1 / 1